Condition
Solitary Pulmonary Nodules
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07087080Not ApplicableRecruitingPrimary
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NCT01465425UnknownPrimary
Extracolonic Findings on Computed Tomography (CT) Colonography
NCT02851368Early Phase 1CompletedPrimary
Near Infrared Fluorescence Imaging With Indocyanine Green
NCT02531646Not ApplicableCompletedPrimary
Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis
NCT00922155Not ApplicableCompleted
Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath
Showing all 5 trials